Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2008
08/07/2008WO2008034912A3 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
08/07/2008US20080188495 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction
08/07/2008US20080188472 Indole-2-Carboxylic Acid Hydrazides
08/07/2008US20080188465 Stable pure anhydrous polymorphic Form I, free of other polymorphs and solvating agents such as water and organic solvents; anti-psychotic agent
08/07/2008CA2676167A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
08/06/2008EP1953148A1 Heterocyclic amide compound and use thereof
08/06/2008EP1953147A1 Heterocyclic compound and medicinal application thereof
08/06/2008EP1951730A1 Heteroalkyl linked pyrimidine derivatives
08/06/2008EP1951729A1 Oxygen linked pyrimidine derivatives
08/06/2008EP1951728A2 Thienopyridine b-raf kinase inhibitors
08/06/2008EP1951727A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
08/06/2008EP1951205A2 Stable composition for a pharmaceutical formulation containing olanzapine
08/06/2008EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
08/06/2008EP1622915B1 Fragrance compositions comprising benzo ¬4,5 thieno¬3,2-b pyran-2-one
08/06/2008CN101237867A Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides
08/06/2008CN101235043A Method for synthesizing visible/near infrared porphyrin used for dyestuff sensitization solar energy battery and application thereof
08/06/2008CN101235042A Preparation and application of center modified porphyrin derivatives with two different kinds of aromatic ring conjugation
08/06/2008CN100408573C Pyrazole compounds useful as protein kinase inhibitors
08/05/2008US7407949 4-(2-Cyclopropyl-ethyl)-piperazine-1-carboxylic acid 2-methyl-4-(3-methyl-4,10-dihydro-3H-2,3,4,9-tetraaza-benzo[f]azulene-9-carbonyl)-benzylamide; inter alia, primary dysmenorrhoea, male erectile dysfunction
08/05/2008CA2142444C Enzymatic asymmetric reduction process to produce 4 h - thieno (2,3-6) thio pyrane derivatives
07/2008
07/31/2008WO2008091770A1 2-aminopyridine derivatives as glucokinase activators
07/31/2008WO2008090140A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments
07/31/2008WO2008070529A3 A2a adenosine receptor antagonists
07/31/2008WO2008051282A3 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine
07/31/2008WO2008013838A3 Pyridizinone derivatives
07/31/2008WO2008005456A3 Fused heterocyclic inhibitors of d-amino acid oxidase
07/31/2008US20080182868 Novel chemical compounds
07/31/2008US20080182862 e.g. 1-(isoquinolin-1-yl)-N3-(2-(pyrrolidin-1-ylmethyl)benzo[d]oxazol-5-yl)-1H-1,2,4-triazole-3,5-diamine; protein tyrosine kinase receptor Axl inhibitor; bioassay; antiinflammatory, anticarcinogenic agent, anticoagulant; rheumatoid arthritis, vascular disease, diabetic retinopathy, osteoporosis
07/30/2008EP1950212A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase
07/30/2008EP1948665A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
07/30/2008EP1948662A2 Tricyclic compounds useful as oxytocin receptor agonists
07/30/2008EP1948601A1 Fab i inhibitor and process for preparing same
07/30/2008EP1658069B1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity
07/30/2008CN101232883A Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them
07/30/2008CN100406461C Sulphur containing heterocyclic and naphthalimides compound and use thereof
07/30/2008CN100406454C Pyrazole compounds useful as protein kinase inhibitors.
07/29/2008US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/29/2008US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
07/29/2008US7405209 Protease inhibitors
07/29/2008CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation
07/29/2008CA2432222C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2432132C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
07/29/2008CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
07/24/2008WO2008089453A2 Inhibitors of d-amino acid oxidase
07/24/2008WO2008088688A1 Substituted spirochromanone derivatives as acc inhibitors
07/24/2008WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
07/24/2008WO2008087277A1 Fluorinated derivative of quinoleine-2(1h)-one, method for preparing the same and use thereof as a synthesis intermediate
07/24/2008WO2008068424A3 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands
07/24/2008WO2008049047A3 Quinoline compounds
07/24/2008WO2008029350B1 An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
07/24/2008WO2007098462A3 Trans-fused chromenoisoquinolines, synthesis and methods for use
07/24/2008US20080176857 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors
07/24/2008US20080176847 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/24/2008CA2676432A1 Inhibitors of d-amino acid oxidase
07/24/2008CA2674573A1 Substituted spirochromanone derivatives
07/23/2008EP1947103A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments
07/23/2008EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors
07/23/2008EP1732933B1 Compounds for treating dyslipidemia
07/23/2008EP1635840B1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors
07/23/2008CN101228154A Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
07/23/2008CN100404539C Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor
07/22/2008US7402600 Nitroderivatives of cardiovascular agents
07/22/2008CA2265095C Pyrazolopyrimidines and pyrazolotriazines
07/17/2008US20080171782 2-[5-(3-Methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil) and derivatives; anticarcinogenic agents; leukemia; antiinflammatory agents; multiple sclerosis, antiarthritic agents; rheumatic diseases;osteoporosis, stroke, asthma; glaucoma; screening; catalyzed CaaX protein methylation
07/17/2008US20080170999 Thienopyrimidines As Cooling Agents
07/16/2008EP1830840B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/16/2008EP1620439B1 New polymorphs of olanzapine hydrochloride
07/16/2008EP1543012B1 6h-thien 2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh)
07/16/2008CN101223178A Therapeutic agents
07/16/2008CN101222024A System for displaying images
07/16/2008CN101220038A 3,4-ethylene dioxythiophene synthesizing method
07/16/2008CN100402533C Use of naphthacene dithiinthianthrene hexadone as third order nonlinear optical material
07/15/2008US7399878 Pharmaceutical compounds
07/15/2008US7399770 N-(hydroxy)-2-(4'-chlorobiphenyl-4-sulfonyl)-4-hydroxy-1,2,3,4-tetrahydrobenzo[4,5]thieno[3,2-c]pyridine-1-carboxamide; collagenase inhibitor; antiinflammatory, angiogenesis agent, wound healing agent; arthritis, multiple sclerosis, osteoarthrosis, atherosclerosis, restenosis, myocardial infarction
07/15/2008US7399764 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer
07/10/2008WO2008083356A1 Substituted triazoles useful as axl inhibitors
07/10/2008WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008WO2008082840A1 Pim kinase inhibitors as cancer chemotherapeutics
07/10/2008WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008WO2008081473A2 Process for preparing clopidogrel
07/10/2008US20080167481 Novel Thiophene Compound and Process for Producing Caffenofuran or Analogue Thereof from the Same
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/10/2008US20080167304 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
07/10/2008CA2710051A1 Substituted triazoles useful as axl inhibitors
07/10/2008CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/09/2008EP1942110A1 Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compounds
07/09/2008EP1940819A1 Phosphodiesterase 10 inhibitors
07/09/2008EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers
07/09/2008EP1753512B1 Tetrahydropyridothiophenes
07/09/2008EP1332133B1 Metabotropic glutamate receptor antagonists
07/09/2008CN101215293A Method for preparing (3aS,6aR)-1,3-substituted benzyl-tetrahydro-1H-thieno[3,4-d]imidazole derivatives
07/09/2008CN101215292A Synthesis method of dibenzylbiotin and its derivatives
07/09/2008CN101215291A Synthesis method of (+)-biotin and its derivatives
07/09/2008CN100400515C Isoquinoline derivatives and methods of use thereof
07/08/2008WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/08/2008US7396942 Dual function UV-absorbers for ophthalmic lens materials
07/08/2008US7396931 Clopidogrel sulfate by reacting a first solvent solution of clopidogrel with sulfuric acid, adding a second solvent to precipitate the salt, and filtering; first and second solvents are acetone and diisopropyl ether or dichloromethane and either diisopropyl ether, cyclohexane or ethyl acetate
07/08/2008US7396930 making spiro(benzo(c)thiophene-1 (3H),4'-piperidine) derivatives; involves reacting a mercapto compound with a 2-halophenylalkyl halide, reacting with an alkyllithium, then N-ethoxycarbonyl-4-piperidone, dehydration and cyclization; industrial scale; novel intermediates to neurokinin receptor antagonist
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 214